All stock lists
Eagle Point Credit Co (New York Stock Exchange:ECC)
US · Delayed Price · Currency is USD
Financial Services · Asset Management
2.63-0.04 (-1.31%)
Market cap
$350M
Insider Score
Health Score
Analyst consensus
Listed since
Oct 8, 2014
Website
Insider Score
––Not scored
ECC Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From ECC’s reported statements · Q2 2026 (trailing 12 months)
Profitability0 / 20
Loses money on what it sells.
- Revenue
- $8.0M
- Net income
- -$166.6M
- Net margin
- -2092.1%
Leverage17 / 20
Little or no net debt.
- Total debt
- $270.0M
- Cash
- $59.5M
- Debt / equity
- 0.32
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $129.8M
- Current liabilities
- $36.5M
- Current ratio
- 3.55
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $77.9M
- Free cash flow
- $77.9M
- FCF margin
- 977.6%
Dilution & runway11 / 20
Some dilution over the past year.
- Shares outstanding
- 133.0M
- Share growth (1y)
- 10.7%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
ECC Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | -62.53 M | 31.44 M | -12.96 M | 52.02 M | 70.84 M | 57.67 M |
| Revenue Growth (YoY) | -188.27 % | -45.48 % | -126.15 % | 10.36 % | 182.03 % | 41.30 % |
| Cost of Revenue | 8.13 M | 9.31 M | 11.46 M | 0.00 | 6.91 M | 12.43 M |
| Gross Profit | -70.66 M | 22.13 M | -24.41 M | 52.02 M | 63.93 M | 45.23 M |
| SG&A Expense | 10.51 M | 10.26 M | -21.18 M | 13.10 M | 2.26 M | 13.07 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | -152.15 M | 158.29 M | 72.81 M | 13.10 M | 2.29 M | 132.61 M |
| Operating Income | 81.49 M | -136.16 M | -97.23 M | 38.91 M | 61.64 M | -87.38 M |
| Pretax Income | 76.26 M | -142.15 M | -104.11 M | 21.76 M | 61.64 M | -94.29 M |
| Tax Provision | 169.17 K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 70.02 M | -148.43 M | -109.95 M | 21.76 M | 61.64 M | -97.53 M |
| EPS (Basic) | 0.53 | -1.12 | -0.83 | 0.18 | 0.48 | -0.81 |
| EPS (Diluted) | 0.53 | -1.12 | -0.83 | 0.18 | 0.48 | -0.81 |
| Shares Outstanding | 133.01 M | 132.53 M | 131.81 M | 120.18 M | 120.18 M | 120.18 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.